By applying this signature to gene expression profiles of purified CD138+ cells, we calculate the plasma cell malignancy (PBM) score, which provides a precise and comprehensive assessment of the malignancy level in MM samples. The gene discussed is SDC1; the disease is Miyoshi myopathy.